Management of patients with hidradenitis suppurativa having underlying genetic variation: a systematic review and a call for precision medicine
Clinical and Experimental Dermatology · 2023
DOI: 10.1093/ced/llac045 ↗At a glance
Systematische Übersicht in Clinical and Experimental Dermatology, 2023. Written by Dillon Mintoff and 2 co-authors. Institution: Department of Dermatology, Mater Dei Hospital, Malta. Major MEDLINE topics: Hidradenitis Suppurativa. Cited 3 times so far (Crossref); 28 references.
Abstract (original language)
Hidradenitis suppurativa (HS) is a chronic inflammatory condition of the pilosebaceous unit characterized by inflammation and hyperkeratinization. A small but significant proportion of patients with HS have a strong genetic susceptibility to (or a syndromic form of) the disease. Current HS treatment guidelines prioritize patients who manifest classic HS and may therefore not be suitable for the minority of patients harbouring genetically driven forms of disease. In this manuscript, we review the extant literature with regards to therapeutic strategies used for patients with HS having disease-associated genetic variants and syndromic forms of the condition. The findings of this review suggest that patients with HS harbouring underlying genetic variants may not be adequately represented in current European and British HS treatment guidelines. Moreover, these patients may be less responsive to the recommended therapeutic options. We therefore make recommendations for future therapeutic guidelines to incorporate considerations for the management of this patient subset.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Department of Dermatology, Mater Dei Hospital, Malta.
- Department of Pathology, Faculty of Medicine and Surgery, University of Malta, Malta.
- Department of Anatomy, Faculty of Medicine and Surgery, University of Malta, Malta.
- Centre for Molecular Medicine and Biobanking, University of Malta, Malta.
- Department of Pathology, Mater Dei Hospital, Malta.
ORCID profiles: Dillon Mintoff, Nikolai P Pace, Isabella Borg
Cite
APA
Mintoff, D., Pace, N. P., & Borg, I. (2023). Management of patients with hidradenitis suppurativa having underlying genetic variation: a systematic review and a call for precision medicine. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llac045
Vancouver
Mintoff D, Pace NP, Borg I. Management of patients with hidradenitis suppurativa having underlying genetic variation: a systematic review and a call for precision medicine. Clinical and Experimental Dermatology. 2023. doi:10.1093/ced/llac045
BibTeX
@article{Mintoff2023,
author = {Mintoff, Dillon and Pace, Nikolai P and Borg, Isabella},
title = {Management of patients with hidradenitis suppurativa having underlying genetic variation: a systematic review and a call for precision medicine},
journal = {Clinical and Experimental Dermatology},
year = {2023},
doi = {10.1093/ced/llac045}
}
EUVIMED